title: Abrogating the induction of type 2 diabetes mellitus secondary to statin therapy.
authors.affiliation: Cleveland Clinic, Mellen Center, 9500 Euclid Avenue, U-10, Cleveland, OH, 44195, USA, planchs@ccf.org.
authors.forename: Sarah M
authors.initials: SM
authors.lastname: Planchon
mesh_terms: D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced*; D005464:Fluorobenzenes / Q000009:adverse effects*; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D007333:Insulin Resistance / Q000235:genetics*; D051059:PTEN Phosphohydrolase / Q000096:biosynthesis*; D011743:Pyrimidines / Q000009:adverse effects*; D000068718:Rosuvastatin Calcium; D013449:Sulfonamides / Q000009:adverse effects*; D015854:Up-Regulation / Q000187:drug effects*
chemical_list: D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides; D000068718:Rosuvastatin Calcium; D051059:PTEN Phosphohydrolase; C487757:Pten protein, mouse